Ziwei Zhou

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

PD-L1-armored CD19/CD22 dual-targeted CAR-T cell co-infusion bridging to allogeneic hematopoietic stem cell transplantation achieves 7-year sustained remission in an adult patient with early relapsed, chemorefractory B-cell acute lymphoblastic leukemia: a case report.

PD-L1-armored CD19/CD22 dual-targeted CAR-T cell co-infusion bridging to allogeneic hematopoietic stem cell transplantation achieves 7-year sustained remission in an adult patient with early relapsed, chemorefractory B-cell acute lymphoblastic leukemia: a case report.

Journal: Frontiers in immunology

Published: January 27, 2026

Immediate versus delayed short-course ruxolitinib for acute GVHD prophylaxis after myeloablative allogeneic hematopoietic stem cell transplantation.

Immediate versus delayed short-course ruxolitinib for acute GVHD prophylaxis after myeloablative allogeneic hematopoietic stem cell transplantation.

Journal: Frontiers in immunology

Published: December 21, 2025

Comprehensive management of hematopoietic stem cell transplantation complications: from infection prevention to immune microenvironment reconstruction.

Comprehensive management of hematopoietic stem cell transplantation complications: from infection prevention to immune microenvironment reconstruction.

Journal: Frontiers in immunology

Published: November 05, 2025

Shoutai pill promotes endometrial decidualization and prevents recurrent spontaneous abortion through dual regulation of apoptosis and ECM remodeling by the LDHA-lactate axis.

Shoutai pill promotes endometrial decidualization and prevents recurrent spontaneous abortion through dual regulation of apoptosis and ECM remodeling by the LDHA-lactate axis.

Journal: Journal of ethnopharmacology

Published: October 29, 2025

Inhibition of EZH2 by SHR2554 modifies subset ratios and suppresses polyfunctional responses of peripheral blood T cells from hematopoietic stem cell donors.

Inhibition of EZH2 by SHR2554 modifies subset ratios and suppresses polyfunctional responses of peripheral blood T cells from hematopoietic stem cell donors.

Journal: International immunopharmacology

Published: March 28, 2025

Effects of Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation After BCMA-CAR T-Cell Therapy on the Survival of Patients With Relapsed or Refractory Multiple Myeloma.

Effects of Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation After BCMA-CAR T-Cell Therapy on the Survival of Patients With Relapsed or Refractory Multiple Myeloma.

Journal: Transplantation and cellular therapy

Published: May 31, 2024

Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma.

Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma.

Journal: Cancer cell international

Published: November 02, 2023

Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.

Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Journal of inflammation research

Published: April 11, 2023

Antibacterial Hydrogel with Self-Healing Property for Wound-Healing Applications.

Antibacterial Hydrogel with Self-Healing Property for Wound-Healing Applications.

Journal: ACS biomaterials science & engineering

Published: October 12, 2021

Pectin-based injectable and biodegradable self-healing hydrogels for enhanced synergistic anticancer therapy.

Pectin-based injectable and biodegradable self-healing hydrogels for enhanced synergistic anticancer therapy.

Journal: Acta biomaterialia

Published: January 29, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026